Front Line interviews PacBio CSO Jonas Korlach about the history of PacBio
(Subscription required) PacBio and Advanced Analytical will jointly promote their long-read sequencing technologies and a new co-developed large-fragment analysis kit […]
Steep Hill is building a full assembly of the 800 million base pairs and 10 chromosomes in cannabis to help […]
(Subscription required) Researchers at UC Davis are working on an assay to record the repeats and methylation status of the […]
This article explains the graphic representation of the Aedes aegypti genome which was sequenced using PacBio technology.
New SMRT Sequencing from Pacific Biosciences could assist researchers seeking to understand the genetic codes of primates, including gorillas. The […]
The sex of human and all mammalian babies may be determined by a simple modification of a virus that insinuated […]
A team of researchers led by UCSF has used SMRT sequencing to unlock the genome of the mosquito responsible for […]
Researchers at MIT and other institutions published in PNAS a new way to discover unknown epigenetic marks and modifications with […]
(Subscription required) At the Advances in Genome Biology and Technology meeting held earlier this month in Orlando, Florida, a number […]
(Subscription required) A team led by researchers at the US DOE’s JGI has successfully created high-resolution phylogenetic profiles for microbial communities using the PacBio RS II platform to generate full-length 16S rRNA sequences, which the researchers have dubbed PhyloTags.
Sequencing firms as well as manufacturers of ancillary equipment and reagents continue to innovate, releasing tools that will both extend the ongoing democratization of technology access and streamline the sample-preparation workflows that drive that equipment on the front end.
A biotech company in Menlo Park is getting widespread attention through a cutting-edge tool it has developed for genetic research.
Biotechniques reviews the best uses for different DNA sequencing technologies, and how sometimes a combination works best.
(Subscription required) CEO Mike Hunkapiller provided attendees of the JP Morgan Healthcare conference an update on the company’s progress, including orders for 49 Sequel Systems in its first quarter of sales.